TrialClinical and molecular hepatology2024

Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients.

Man-Fung Yuen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.